Palatin Technologies
PTN
#9923
Rank
$39.16 M
Marketcap
$23.00
Share price
4.59%
Change (1 day)
2,373.12%
Change (1 year)

Revenue for Palatin Technologies (PTN)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of $0.35 Million USD a decrease over the revenue in the year 2023 that were of $7.09 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Palatin Technologies from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 $0.35 M-95.07%
2023 $7.09 M146.2%
2022 $2.88 M286.68%
2021 $0.74 M-264.75%
2020 -$0.46 Million-100.75%
2019 $60.38 M103.89%
2018 $29.61 M-64.01%
2017 $82.27 M
2016 N/A
2015 N/A-100%
2014 $12.95 M
2013 N/A-100%
2012 $0.04 M-82.26%
2011 $0.25 M-94.31%
2010 $4.49 M-77.9%
2009 $20.33 M445.4%
2008 $3.72 M-75.87%
2007 $15.44 M-17.37%
2006 $18.69 M1.7%
2005 $18.38 M93.58%
2004 $9.49 M274.31%
2003 $2.53 M140.47%
2002 $1.05 M168.31%
2001 $0.39 M-89.86%
2000 $3.87 M35.57%
1999 $2.86 M257.5%
1998 $0.8 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
MediciNova
MNOV
$0.13 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$2.68 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$0.82 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.25 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
$0.19 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$92.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.39 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$58.12 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK